Table 7:
Initial prescription for HTN management among PLHIV diagnosed with HTN (N=192)
| Treatment modality | Initial HTN Prescription | Frequency (n =192) | Percentage |
|---|---|---|---|
| Medicines for HTN treatment (N=181, 94.3%) | |||
| CCB + ACEI | 69 | 35.9 | |
| CCB + Beta blocker | 26 | 13.5 | |
| CCB | 22 | 11.5 | |
| CCB + Thiazide diuretic | 21 | 10.9 | |
| CCB + ARB | 18 | 9.4 | |
| Thiazide diuretic + Beta blocker | 16 | 8.3 | |
| Thiazide diuretic + ARB | 3 | 1.6 | |
| CCB + Thiazide diuretic + Furosemide | 2 | 1.0 | |
| Other medicines combinations | 4 | 2.1 | |
| Lifestyle modification (N=11, 5.7%) | |||
| Lifestyle modification | 11 | 5.7 | |
CCB= Calcium channel blocker, ACEI=Angiotensin converting enzyme inhibitors, ARB=angiotensin receptor blocker